107 related articles for article (PubMed ID: 1678889)
1. Inhibitory effect of streptozotocin on tumor development in transgenic mice bearing an elastase I-SV40 T-antigen fusion gene.
Bell RH; Brinck-Johnsen T; Longnecker DS
Pancreas; 1991 Jul; 6(4):475-8. PubMed ID: 1678889
[TBL] [Abstract][Full Text] [Related]
2. Hyperplasia and tumors of the islets of Langerhans in mice bearing an elastase I-SV40 T-antigen fusion gene.
Bell RH; Memoli VA; Longnecker DS
Carcinogenesis; 1990 Aug; 11(8):1393-8. PubMed ID: 2167183
[TBL] [Abstract][Full Text] [Related]
3. Pancreatic neoplasia induced by SV40 T-antigen expression in acinar cells of transgenic mice.
Ornitz DM; Hammer RE; Messing A; Palmiter RD; Brinster RL
Science; 1987 Oct; 238(4824):188-93. PubMed ID: 2821617
[TBL] [Abstract][Full Text] [Related]
4. Transgenic mice carrying a murine amylase 2.2/SV40 T antigen fusion gene develop pancreatic acinar cell and stomach carcinomas.
Ceci JD; Kovatch RM; Swing DA; Jones JM; Snow CM; Rosenberg MP; Jenkins NA; Copeland NG; Meisler MH
Oncogene; 1991 Feb; 6(2):323-32. PubMed ID: 1705690
[TBL] [Abstract][Full Text] [Related]
5. Cholecystokinin receptor characterization and cholecystokinin-A receptor messenger RNA expression in transgenic mouse pancreatic carcinomas and dysplastic pancreas.
Povoski SP; Zhou W; Longnecker DS; Bell RH
Oncol Res; 1994; 6(9):411-7. PubMed ID: 7703527
[TBL] [Abstract][Full Text] [Related]
6. The c-myc and PyMT oncogenes induce different tumor types in a somatic mouse model for pancreatic cancer.
Lewis BC; Klimstra DS; Varmus HE
Genes Dev; 2003 Dec; 17(24):3127-38. PubMed ID: 14681205
[TBL] [Abstract][Full Text] [Related]
7. Timely immunization subverts the development of peripheral nonresponsiveness and suppresses tumor development in simian virus 40 tumor antigen-transgenic mice.
Ye X; McCarrick J; Jewett L; Knowles BB
Proc Natl Acad Sci U S A; 1994 Apr; 91(9):3916-20. PubMed ID: 8171012
[TBL] [Abstract][Full Text] [Related]
8. Inactivation of p53 and the development of tetraploidy in the elastase-SV40 T antigen transgenic mouse pancreas.
Ramel S; Sanchez CA; Schimke MK; Neshat K; Cross SM; Raskind WH; Reid BJ
Pancreas; 1995 Oct; 11(3):213-22. PubMed ID: 8577673
[TBL] [Abstract][Full Text] [Related]
9. Formation of the tetraploid intermediate is associated with the development of cells with more than four centrioles in the elastase-simian virus 40 tumor antigen transgenic mouse model of pancreatic cancer.
Levine DS; Sanchez CA; Rabinovitch PS; Reid BJ
Proc Natl Acad Sci U S A; 1991 Aug; 88(15):6427-31. PubMed ID: 1650467
[TBL] [Abstract][Full Text] [Related]
10. Cell lines derived from pancreatic tumors of Tg(Ela-1-SV40E)Bri18 transgenic mice express somatostatin and T antigen.
Pettengill OS; Memoli VA; Brinck-Johnsen T; Longnecker DS
Carcinogenesis; 1994 Jan; 15(1):61-5. PubMed ID: 7904904
[TBL] [Abstract][Full Text] [Related]
11. A simian virus 40 large T-antigen segment containing amino acids 1 to 127 and expressed under the control of the rat elastase-1 promoter produces pancreatic acinar carcinomas in transgenic mice.
Tevethia MJ; Bonneau RH; Griffith JW; Mylin L
J Virol; 1997 Nov; 71(11):8157-66. PubMed ID: 9343166
[TBL] [Abstract][Full Text] [Related]
12. Acinar-to-ductal metaplasia accompanies c-myc-induced exocrine pancreatic cancer progression in transgenic rodents.
Grippo PJ; Sandgren EP
Int J Cancer; 2012 Sep; 131(5):1243-8. PubMed ID: 22024988
[TBL] [Abstract][Full Text] [Related]
13. Transgene expression and repression in transgenic rats bearing the phosphoenolpyruvate carboxykinase-simian virus 40 T antigen or the phosphoenolpyruvate carboxykinase-transforming growth factor-alpha constructs.
Haas MJ; Dragan YP; Hikita H; Shimel R; Takimoto K; Heath S; Vaughan J; Pitot HC
Am J Pathol; 1999 Jul; 155(1):183-92. PubMed ID: 10393850
[TBL] [Abstract][Full Text] [Related]
14. Diet-dependent carcinogenesis of pancreatic islets and liver in transgenic mice expressing oncogenes under the control of the L-type pyruvate kinase gene promoter.
Cartier N; Miquerol L; Tulliez M; Lepetit N; Levrat F; Grimber G; Briand P; Kahn A
Oncogene; 1992 Jul; 7(7):1413-22. PubMed ID: 1620553
[TBL] [Abstract][Full Text] [Related]
15. [Insulinoma originating from transplanted pancreatic cells after low dose portal embolic islet transplantation in streptozotocin diabetic rats].
Dombrowski F; Pfeifer U
Verh Dtsch Ges Pathol; 1997; 81():162-8. PubMed ID: 9474868
[TBL] [Abstract][Full Text] [Related]
16. Conditional transformation of a pancreatic beta-cell line derived from transgenic mice expressing a tetracycline-regulated oncogene.
Efrat S; Fusco-DeMane D; Lemberg H; al Emran O; Wang X
Proc Natl Acad Sci U S A; 1995 Apr; 92(8):3576-80. PubMed ID: 7724601
[TBL] [Abstract][Full Text] [Related]
17. Endocrine pancreatic tumors in MSV-SV40 large T transgenic mice.
Götz W; Schucht C; Roth J; Theuring F; Herken R
Am J Pathol; 1993 May; 142(5):1493-503. PubMed ID: 8388173
[TBL] [Abstract][Full Text] [Related]
18. Generation and characterization of islet cell tumor in pTet-on/pTRE-SV40Tag double-transgenic mice model.
Shen Q; Sun Q; Wei X; Dong J; Zhang R; Wu P; Jin Y; Feng J; Li H; Hu Y
J Biosci Bioeng; 2007 Jul; 104(1):14-21. PubMed ID: 17697978
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of streptozotocin-induced islet cell tumors and N-nitrosobis(2-oxopropyl)amine-induced pancreatic exocrine tumors in Syrian hamsters by exogenous insulin.
Pour PM; Kazakoff K; Carlson K
Cancer Res; 1990 Mar; 50(5):1634-9. PubMed ID: 2154330
[TBL] [Abstract][Full Text] [Related]
20. Influence of diabetes on susceptibility to experimental pancreatic cancer.
Bell RH; McCullough PJ; Pour PM
Am J Surg; 1988 Jan; 155(1):159-64. PubMed ID: 2963553
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
